Argus Pharmaceuticals Inc., Genzyme deal

The companies will collaborate to develop ARGS' Tretinoin, a lipid-based intravenous form of tretinoin, for anti-cancer therapy.

Read the full 178 word article

How to gain access

Continue reading with a
two-week free trial.